Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Ra2-CAR T Cells but Results in Antigen Loss Variants.

Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Ra2-CAR T Cells but Results in Antigen Loss Variants. Cancer Immunol Res. 2017 07; 5(7):571-581.

View in: PubMed

subject areas

Animals
Antigens, Neoplasm
Cell Line, Tumor
Cell Proliferation
Glioblastoma
Humans
Immunotherapy, Adoptive
Interleukin-13 Receptor alpha2 Subunit
Interleukin-15
Lymphocyte Activation
Mice
Mice, Transgenic
Receptors, Antigen, T-Cell
T-Lymphocytes
Xenograft Model Antitumor Assays

authors with profiles

STEPHEN GOTTSCHALK